Ebunat 0.5 mg Injection
222,12$
173,25$
Ebunat 0.5 mg Injection is a targeted anticancer therapy designed for patients battling metastatic breast cancer who have already undergone at least two lines of chemotherapy. This medication is also indicated for individuals with unresectable liposarcoma that have previously received anthracycline-based treatments for advanced or metastatic disease. By inhibiting the growth and proliferation of cancer cells, Ebunat works effectively to manage these challenging conditions. It is crucial for patients to be aware of potential side effects and to consult their healthcare provider regarding any pre-existing health concerns, especially those related to heart function. As with any anticancer treatment, monitoring during therapy is essential to ensure the best outcomes and manage any adverse reactions. Patients are advised to discuss their complete medical history with their doctor before starting treatment with Ebunat. This injection not only aims to improve survival rates but also enhances the quality of life for those facing aggressive cancer types. With careful administration and professional oversight, Ebunat 0.5 mg can play a significant role in the cancer treatment landscape.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Ebunat 0.5 mg injection is primarily indicated for the treatment of metastatic breast cancer. This condition occurs when cancer cells spread from the breast to other parts of the body, such as the bones or lungs. Patients may experience symptoms like pain in the affected areas and difficulty breathing. Ebunat 0.5 mg injection helps manage these symptoms and improve overall quality of life.
• In patients diagnosed with metastatic breast cancer, Ebunat 0.5 mg injection plays a crucial role in alleviating discomfort associated with the disease. The medication can reduce pain and swelling, allowing patients to engage more comfortably in daily activities. By addressing these physical symptoms, Ebunat 0.5 mg injection supports better functional outcomes for individuals undergoing treatment.
• Ebunat 0.5 mg injection is utilized in various treatment regimens for metastatic breast cancer to help enhance patient well-being. It can be administered alongside other therapeutic agents to provide comprehensive care. The injection can assist in reducing the severity of symptoms such as persistent cough or shortness of breath. This multifaceted approach aims to improve the overall management of the disease.
• Patients receiving Ebunat 0.5 mg injection may find relief from the debilitating effects of metastatic breast cancer. This medication can help mitigate weight loss and loss of appetite, common challenges faced by those with advanced cancer. By improving these aspects, Ebunat 0.5 mg injection contributes to better nutritional status and energy levels. Ultimately, it aims to support a more favorable treatment journey for those affected.
Benefits
Metastatic breast cancer is a type of advanced breast cancer that has spread beyond the breast and nearby lymph nodes to other parts of the body, such as the bones, liver, lungs, or brain. Ebunat 0.5 mg Injection is used when other medicines have not shown significant improvement and cancer has spread to other parts as well. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Ebunat 0.5 mg kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Soft tissue sarcoma (Liposarcoma): soft tissue sarcoma is a group of cancers that develop in the soft tissues of the body, such as the muscles, fat, nerves, blood vessels, and connective tissues. This medicine is used who have received prior anthracycline-containing therapy and have not shown significant improvement. Ebunat 0.5 mg Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
Side Effects
Ebunat 0.5 mg Injection may cause some side effects. If you experience any of these side effects contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Breathlessness
• Risk of Infection
• Loss of appetite
• Headaches
• Numbness or tingling in toes and fingers
• Cough
• Feeling sick
• Diarrhoea
• Constipation
• Hair loss
• Body Pain
• Fever
• Fatigue
• Weight loss
Common Side Effects
• Sepsis
• Blood clot in veins
• Inflammation of the pancreas
• Liver Damage
• Protein and blood in your urine
• Severe skin reaction
• Bruising and bleeding
• Changes in heartbeat
How To Use
Ebunat 0.5 mg is given intravenously (in vein) or as an intravenous infusion over 2 to 5 minutes by a healthcare professional, doctor or nurse in a hospital. The dosage and frequency of Ebunat 0.5 mg depend on various factors, including your weight and height, your health problems and what type of cancer and condition you have. Your health professional may decrease your dose or delay your treatment if you experience serious side effects. While during the treatment closely monitor the patient while blood cell count, peripheral neuropathy signs and symptoms.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Ebunat 0.5 mg Injection. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: patients with kidney disease should closely monitor kidney function while taking Ebunat 0.5 mg and report any unusual symptoms or changes in kidney function to their physician. The dose of Ebunat 0.5 mg should be used with caution in patients with kidney disease. It is important to adjust the dose in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Ebunat 0.5 mg. Ebunat 0.5 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Ebunat 0.5 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Ebunat 0.5 mg Injection should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Ebunat 0.5 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Ebunat 0.5 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Ebunat 0.5 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Ebunat 0.5 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Ebunat 0.5 mg may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Ebunat 0.5 mg.